Prognostic factors for TB-associated uveitis in the Asia-Pacific Region: results of a modified Delphi survey


Prognostic factors for TB-associated uveitis (TBU) remain mostly unknown, due to the challenges in interpretation of patient data. We present consensus list of prognostic factors for resolution of inflammation in TBU, by experts across the Asia-Pacific region.



We applied a modified Delphi technique to generate consensus on prognostic factors influencing the resolution of inflammation in TB-associated: anterior uveitis (AU), retinal vasculitis (RV), and multifocal serpiginoid choroiditis (MSC). The initial questionnaire was developed through a face-to-face meeting. Sixteen uveitis experts from eleven Asia-Pacific countries were included. A single investigator circulated the questionnaire electronically and received the responses. Participants scored each item on 4-point Likert scale, in three successive rounds. After each round, a number of items were reduced based on response, and summary of responses was provided to participants. At the end of Round 3, items were considered significant if they: (1) achieved a median ≥2, and interquartile range ≤1, and (2) ≥75% of the respondents agreed on whether the item was a positive or negative prognostic factor.



Forty-two putative questionnaire items were considered. At the end of Rounds 3, 4, 9, and 8 items in AU, RV, and MSC, respectively, met significance criteria. These included duration of disease, previous corticosteroid/immunosuppressive therapy, co-existent HIV, disease-specific imaging features, multidrug resistant TB, and duration of anti-TB therapy.



Consensus were achieved on multiple ocular and systemic factors that influence resolution of inflammation in TBU. These will form the groundwork for validation in prospective clinical trials.



Basu, S., La Distia Nora, R., Rao, N.A. et al. Prognostic factors for TB-associated uveitis in the Asia-Pacific Region: results of a modified Delphi survey. Eye 34, 1693–1701 (2020). https://doi.org/10.1038/s41433-019-0743-1


Link di sini.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Call for more investment in cost-effective tuberculosis care
18 Juni 2021
The global community is facing a considerable challenge to eliminate tuberculosis (TB). Although the...
Good Knowledge but Poor Practice Toward COVID-19 Among Indonesian Youth
18 Juni 2021
COVID-19 cases have been increasing among young people as they are often considered to have low compliance...
Targeted vaccine allocation could increase the covid-19 vaccine benefits amidst its lack of availability: A mathematical modeling study in indonesia
18 Juni 2021
With a limited number of vaccines and healthcare capacity shortages, particularly in low-and middle-income...
COVID-19 and tuberculosis-related catastrophic costs
28 Maret 2021
The COVID-19 pandemic has created an unprecedented health crisis and a substantial socioeconomic impact....
Cost of seeking care for tuberculosis since the implementation of universal health coverage in Indonesia
28 Maret 2021
Background Although tuberculosis (TB) patients often incur high costs to access TB-related services,...
Catastrophic costs due to tuberculosis worsen treatment outcomes: a prospective cohort study in Indonesia
28 Maret 2021
Background While the incidence of catastrophic costs due to tuberculosis (TB) remains high, there...
Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios
28 Maret 2021
Background The World Health Organization’s End Tuberculosis Strategy states that no tuberculosis (TB)-affected...
A health economic evaluation of using N-terminal pro brain natriuretic peptide for the management of acute heart failure: A pilot study in an Indonesian tertiary referral hospital
28 Maret 2021
Heart failure represents a major health problem and economic burden also in development countries such...
Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage
28 Maret 2021
Background As well as imposing an economic burden on affected households, the high costs related to...
Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households
28 Maret 2021
BACKGROUND:Indonesia is the second-highest country for tuberculosis (TB) incidence worldwide. Hence,...